GLP1R and obesity disorder: In addition, anti-obesity drugs [3], such as the GLP-1 receptor agonist semaglutide (trade names: Wegovy and Ozempic) are effective in causing major weight loss in patients with obesity through the suppression of appetite and food intake [4, 5].